(Last updated : 2019-11-15 14:27:47)
  Fujimoto Naohiro
   Department   School of Medicine  Urology, Clinical Medical Sciences
   Position  
■ Journal
1.   Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer. 2019/08 Link
2.   Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men. 2019/06 Link
3.   The Role of Nuclear Receptors in Prostate Cancer. 2019/06 Link
4.   The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men. 2019/05 Link
5.   Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone. 2019/02 Link
Display all(55)
■ Presentation
1. Intermittent androgen suppression in patients with recurrence after radiotherapy for prostate cancer  2018/10/18
2. Efficacy and tolerability of Paclitaxel-Gemcitabine therapy for urothelial carcinoma in
patients who have received prior platinum-based chemotherapy.  2018/02
3. Independent validation of missense polymorphism in HSD3B1 in Japanese men
treated with primary androgen-deprivation therapy for metastatic prostate cancer.  2018/02
4. Cessation of primary androgen deprivation therapy for men with localized prostate cancer;Is it acceptable?  2017/10/20
5. Second transurethral resection for T1 bladder cancer; Is it necessary?  2017/10/20
Display all(13)
■ Present specialized field
Urology 
■ Academic background
1. 〔Doctoral course〕, University of Occupational and Environmental Health, Japan, Completed,
■ Business career
1. 2015/02~ School of Medicine Clinical Medical Sciences Urology